Pharmaceuticals: Major
Major Egyptian companies producing pharmaceuticals
Global pharmaceutical corporations develop and distribute prescription medications at a massive scale. Patent expirations, pipeline approvals, and healthcare legislation serve as major catalysts for trading activity and industry liquidity. Market data indicates that Macro Group Pharmaceutical S.A.E. is currently the highest-volume asset, while Sabaa International Company for Pharmaceutial and Chemical Industry tops the 24-hour return list. The table below tracks the vital technical and fundamental metrics for these equities.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 13.9 B EGP | 281.00 EGP | +1.08% | 469.44 K | 0.88 | 45.14 | 6.23 EGP | +17.60% | 0.72% | Health technology | No rating | |
| 11.14 B EGP | 5.50 EGP | +0.36% | 8.38 M | 1.47 | 32.47 | 0.17 EGP | +38.40% | 0.55% | Health technology | Neutral | |
| 9 B EGP | 793.85 EGP | −0.63% | 452 | 0.14 | — | — | — | 0.31% | Health technology | No rating | |
| 8.98 B EGP | 601.50 EGP | +0.06% | 5.82 K | 0.71 | 16.26 | 37.00 EGP | +24.52% | 2.78% | Health technology | No rating | |
| 7.11 B EGP | 317.00 EGP | +1.40% | 429.21 K | 1.24 | 13.91 | 22.78 EGP | +26.55% | 4.22% | Health technology | No rating | |
| 6.6 B EGP | 1,335.01 EGP | +0.53% | 2.88 K | 0.79 | — | — | — | 4.77% | Health technology | No rating | |
| 4.51 B EGP | 1.34 EGP | +1.52% | 36.09 M | 1.14 | — | — | — | 0.00% | Health technology | No rating | |
| 4.49 B EGP | 187.21 EGP | +0.13% | 53 K | 2.58 | — | — | — | 0.00% | Health technology | No rating | |
| 3.08 B EGP | 260.00 EGP | +1.39% | 9.83 K | 1.07 | 13.43 | 19.37 EGP | +16.81% | 3.25% | Health technology | No rating | |
| 1.17 B EGP | 5.08 EGP | +8.78% | 19.29 M | 3.08 | — | −0.01 EGP | +82.95% | 0.00% | Health technology | No rating |